A new-generation continuous glucose monitoring system: Improved accuracy and reliability compared with a previous-generation system

Diabetes Technology and Therapeutics

Volumn 15, Issue 10, 2013, Pages 881-888

  Christiansen, Mark ^a   Bailey, Timothy ^b   Watkins, Elaine ^c   Liljenquist, David ^d   Price, David ^e   Nakamura, Katherine ^e   Boock, Robert ^e   Peyser, Thomas ^e  

^a Diablo Clinical Research   (United States)

^b AMCR Institute Inc   (United States)

^c Department of Profil ^*  (United States)

^d Rocky Mt Diabet Osteoporosis Ctr   (United States)

^e DexCom Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYZER; ARTICLE; BLOOD GLUCOSE ANALYZER; BLOOD GLUCOSE MONITORING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANXIETY; BIOSENSING TECHNIQUES; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; UNITED STATES;

EID: 84884562284     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0077     Document Type: Article

References (39)

1. American Diabetes Association: Standards of medical care in diabetes-2012. Diabetes Care 2012;35(Suppl 1):S11-S63.
2. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F: Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007;30:1653-1662. (Pubitemid 46871195)
3. Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovic L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV, Rothermel C: Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring. Endocr Pract 2010;16: 730-745.
4. Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H: Continuous glucose monitoring: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:2968-2979.
5. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) Trial. Diabetes Care 2010; 33:17-22.
7. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using realtime continuous glucose monitoring. Diabetes Care 2006;29: 2730-2732. (Pubitemid 44912209)
8. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA: Sensor-augmented insulin pump therapy: results of the first randomized Treat-to-Target Study. Diabetes Technol Ther 2008;10:377-383.
9. Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M: Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the Realtrend Study. Diabetes Care 2009;32:2245-2250.
10. O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ: Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009; 52:1250-1257.
11. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34: 795-800.
12. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649. (Pubitemid 44912192)
13. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50. (Pubitemid 44033429)
14. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM: Short-and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 2012;35:32-38.
15. Bailey TS, Zisser HC, Garg SK: Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 2007;9:203-210. (Pubitemid 46959785)
16. Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV: Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-1953.
17. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA: The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012;97:4383-4389.
18. Hermanides J, Phillip M, DeVries JH: Current application of continuous glucose monitoring in the treatment of diabetes. Diabetes Care 2011;34(Suppl 2):S197-S201.
19. Bartelme A, Bridger P: The role of reimbursement in the adoption of continuous glucose monitors. J Diabetes Sci Technol 2009;3:992-995.
20. CGM resource center. Practice management: CGM reimbursement. http://thecgmresourcecenter.com/practice-management/cgm-reimbursement (accessed August 2012).
21. Ramchandani N, Arya S, Ten S, Bhandari S: Real-life utilization of real-time continuous glucose monitoring: the complete picture. J Diabetes Sci Technol 2011;5:860-870.
22. Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D: A randomized multicenter trial comparing the Glucowatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005;28: 1101-1106. (Pubitemid 40616619)
23. Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, Mauras N, Ruedy KJ, Tansey M, Weinzimer SA, Wysocki T: Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007;151: 388-393.
24. Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K: Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes 2009;10:91-96.
25. Buckingham B, Block J, Burdick J, Kalajian A, Kollman C, Choy M, Wilson DM, Chase P: Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther 2005;7:440-447. (Pubitemid 40847806)
26. Chia CW, Saudek CD: Glucose sensors: toward closed loop insulin delivery. Endocrinol Metab Clin North Am 2004;33: 175-195. (Pubitemid 38438430)
27. Hovorka R: Continuous glucose monitoring and closed-loop systems. Diabet Med 2006;23:1-12.
28. Mazze RS, Strock E, Borgman S, Wesley D, Stout P, Racchini J: Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time Diabetes Technol Ther 2009;11:11-18.
29. Hessler DP, Polonsky WH, Bowman F, Price D: The subjective experience of CGM-RT use: comparing current users with ex-users [abstract]. Diabetes 2012;61:A215.
30. Diabetes Research in Children Network (DirecNet) Study Group: The accuracy of the Glucowatch G2 Biographer in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther 2003;5:791-800.
31. U.S. Food and Drug Administration. Summary of safety and effectiveness data. www.Fda.Gov/ohrms/dockets/dockets/05m0454/05m-0454-aav0001-03-ssed-vol1. Pdf (accessed August 2012).
32. U.S. Food and Drug Administration. Summary of safety and effectiveness data. 2006. www.Accessdata.Fda.Gov/cdrh-docs/pdf5/p050012b.Pdf (accessed August 2012).
33. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV: Accuracy of the 5-day Freestyle Navigator continuous glucose monitoring system: comparison with frequent laboratory reference measurements. Diabetes Care 2007;30:1125-1130. (Pubitemid 46684636)
34. Zisser HC, Bailey TS, Schwartz S, Ratner RE, Wise J: Accuracy of the seven continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sci Technol 2009;3:1146-1154.
35. Bailey T, Zisser H, Chang A: New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time. Diabetes Technol Ther 2009;11:749-755.
36. Cryer PE: Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract 2008;14: 750-756.
37. Davey RJ, Stevens K, Jones TW, Fournier PA: The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus. Prim Care Diabetes 2012;6:35-39.
38. Wojciechowski P, Ryś P, Lipowska A, Gaweska M, Ma1ecki MT: Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. Pol Arch Med Wewn 2011;121:333-343.
39. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628. (Pubitemid 17158937)